Alkem Laboratories Ltd

Founded: 1973 • Age: 53 yrs
Production of FOS and related dietary fibers for food and health applications in India.

About Alkem Laboratories Ltd

Alkem Laboratories Ltd is a Consumer company founded in 1973. Production of FOS and related dietary fibers for food and health applications in India. It operates in the Consumer and Healthcare sectors. The company has 18,642 employees. Its Indian entity Alkem Laboratories Limited reported revenue of β‚Ή15,310 Cr. Alkem Laboratories Ltd offers products and services including FOSHealth and Prebiotic Fibers. Its focus areas include Food and Beverages, Food Additives, Dietary Fibers and Natural Sweeteners.

Company details

Alkem Laboratories Ltd is identified as the first manufacturer of FOS in India, a natural dietary fiber that is not broken down in the stomach and small intestine. It is fermented in the large intestine, where it fosters the growth of healthy bacteria and inhibits harmful ones, thereby supporting digestive and immune functions. FOS is employed as a sugar substitute in foods like cereals, beverages, and confectionery, offering low calories, high solubility, and benefits for weight management and nutrition. Enquiries are directed through provided contact details for further information.

  • Employees 18,642
  • Sectors
    Consumer
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website foshealth.in
  • Social LinkedIn X Facebook
  • Legal Name Alkem Laboratories Ltd
  • Date of Incorporation 08 Aug, 1973
  • Jurisdiction Mumbai, Maharashtra, India
Key Metrics
  • Indian entity revenue
    ₹15,310 Cr

    FY 2026 · +13% YoY

  • Indian entity net profit
    ₹2,440 Cr

    FY 2026 · 16% margin

  • Indian entity EBITDA
    ₹2,816 Cr

    FY 2026 · 18% margin

  • Employee Count
    18,642

Products & Services of Alkem Laboratories Ltd

Alkem Laboratories Ltd offers a comprehensive portfolio of products and services, including FOSHealth and Prebiotic Fibers.

FOSHealth
Dietary Fibers

FOSHealth is manufactured as a natural prebiotic fiber that serves as a sugar substitute in food and beverages, with properties that support digestive health and nutritional enhancement.

Prebiotic Fibers
Health Supplements

Prebiotic fibers are produced to aid in weight management and mineral absorption, being integrated into products that promote digestive and overall health benefits.

Board of directors of Alkem Laboratories Limited (Alkem Laboratories Ltd)

Alkem Laboratories Limited is the primary company behind Alkem Laboratories Ltd. The board of Alkem Laboratories Limited currently have 12 directors; the longest-serving is Basudeo Narayan Singh, appointed in 1973. 17 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Basudeo Narayan Singh
DIN 00760310
Whole-time director08 Aug 197353 yrs 3 moAlkem Laboratories Limited
Mritunjay Kumar Singh
DIN 00881412
Whole-time director11 Feb 200818 yrs 9 moAlkem Laboratories Limited
Sandeep Singh
DIN 01277984
Managing Director09 Aug 201313 yrs 3 moAlkem Laboratories Limited
Sarvesh Singh
DIN 01278229
Whole-time director11 Nov 20197 yrsAlkem Laboratories Limited
Narendra Kumar Aneja
DIN 00124302
Director16 Mar 20206 yrs 7 moAlkem Laboratories Limited
Madhurima Singh
DIN 09137323
Whole-time director20 Dec 20214 yrs 10 moAlkem Laboratories Limited
Sujjain Suresh Talwar
DIN 01756539
Director05 Aug 20224 yrs 3 moAlkem Laboratories Limited
Srinivas Balmiki Prasad Singh
DIN 06744441
Whole-time director14 Sep 20224 yrs 1 moAlkem Laboratories Limited
Rajeev Kher
DIN 01192524
Director09 Aug 20242 yrs 3 moAlkem Laboratories Limited
Laxmana Ranjal Shenoy
DIN 00074761
Director13 Jul 20251 yr 4 moAlkem Laboratories Limited
Neela Bhattacherjee
DIN 01912483
Director13 Jul 20251 yr 4 moAlkem Laboratories Limited
Diwakar Gupta
DIN 01274552
Director13 Jul 20251 yr 4 moAlkem Laboratories Limited

Financials of Alkem Laboratories Ltd

Figures of Alkem Laboratories Limited, the primary company behind Alkem Laboratories Ltd, for FY 2026. Revenue was ₹15,310 Cr (+13% year on year). Net profit was ₹2,440 Cr (16% margin). EBITDA was ₹2,816 Cr (18% margin). Revenue has grown at a compounded annual rate of +8% over three years and +11% over five years.

  • ₹15,310 CrRevenue · FY 2026 · +13% YoY
  • ₹2,440 CrNet profit · 16% margin
  • ₹2,816 CrEBITDA · 18% margin
  • ₹23.91 CrPaid-up capital
  • 18,498Employees (provident fund records)
  • +8%Revenue CAGR, 3 years
  • +11%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Alkem Laboratories Limited are on its company page.

Premium access

Detailed financial statements for Alkem Laboratories Ltd

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Alkem Laboratories Ltd

ALKEM: Q2 CONS NET PROFIT 6.7B RUPEES VS 7.7B (YOY); EST 6.9B
Exchange Update β€’ today
ALKEM: Q2 EBITDA 10.25B RUPEES VS 9.21B (YOY); Q2 EBITDA MARGIN 22.52% VS 23.01% (YOY)
Exchange Update β€’ today
ALKEM: Q2 REVENUE 45.52B RUPEES VS 40.01B (YOY)
Exchange Update β€’ today
ALKEM: Q2 EBITDA MARGIN AT 22.5% VS FY27 GUIDANCE OF 20%
Exchange Update β€’ today
ALKEM LAB: Q2 US SALES GREW 2.4% VS FY27 GUIDANCE HIGH SINGLE-DIGIT
Exchange Update β€’ today
Alkem Laboratories: Appoints MR. Gopal Kothari As Chief Financial Officer Effective From December 2, 2026; He Brings Over 24 Years Of Experience In Financial Planning And Analysis.
Exchange Update β€’ today
Alkem Laboratories: Names Dr. Amrut Naik As New CEO
Exchange Update β€’ 9 days ago
Alkem Laboratories: API Facility Passes US FDA Inspection With No Issues Found
Exchange Update β€’ 13 days ago
Alkem Laboratories: Company's Audit Committee Greenlights Forensic Audit by Grant Thornton Over Alleged Fund Misuse by Ex-Employee.
Exchange Update β€’ 22 days ago
ALKEM: Rs. 26.69 Crores NSE Block Trade; for ~ 50,611 Shares, at Rs. 5274.00
Exchange Update β€’ 1 month ago
Premium access

Complete news archive for Alkem Laboratories Ltd

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Alkem Laboratories Ltd

Alkem Laboratories Ltd was founded in 1973.

Alkem Laboratories Ltd has 18,642 employees.

The primary company behind Alkem Laboratories Ltd, Alkem Laboratories Limited, reported revenue of β‚Ή15,310 Cr for FY 2026, up 13% year on year.

Alkem Laboratories Ltd is identified as the first manufacturer of FOS in India, a natural dietary fiber that is not broken down in the stomach and small intestine. It is fermented in the large intestine, where it fosters the growth of healthy bacteria and inhibits harmful ones, thereby supporting digestive and immune functions. FOS is employed as a sugar substitute in foods like cereals, beverages, and confectionery, offering low calories, high solubility, and benefits for weight management and nutrition. Enquiries are directed through provided contact details for further information.

Alkem Laboratories Ltd offers FOSHealth and Prebiotic Fibers.

Alkem Laboratories Ltd operates through Alkem Laboratories Limited.

The legal entities of Alkem Laboratories Ltd currently have 13 directors, including Manish Narang, Sujjain Suresh Talwar, Srinivas Balmiki Prasad Singh and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available